Investigation of Cigarette Cravings in Smokers

NCT ID: NCT04843969

Last Updated: 2021-04-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-20

Study Completion Date

2022-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Interventions to disrupt memory reconsolidation have held promise for the treatment of stress- and anxiety-related disorders. In the present study, the investigators will examine whether an intervention based on these principles, called memory updating, could be adapted for reward-seeking behaviors. To test this, non-treatment seeking tobacco smokers will be exposed to smoking cues and/or stress, two stimuli known to trigger smoking. It is predicted that exposure to a stress task will enhance the cues' motivational salience and yield greater susceptibility to the memory updating procedure.

As an add-on, the investigators will examine COVID-associated changes in substance use and whether participants in the memory updating groups might be more resilient to these effects. It is predicted that the changes in substance use will depend on whether the substances are used primarily in social settings.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Non-treatment seeking cigarette dependent smokers will be randomized to one of four testing conditions: 1) a non-stressful task followed by neutral cues, 2) the non-stressful task followed by smoking cues, 3) a stressful task followed by neutral cues, or 4) the stressful task followed by smoking cues. Ten minutes after the intervention, participants will undergo a 60-minute extinction procedure consisting of smoking-related videos, images and smoking paraphernalia. Cue reactivity test sessions will take place 24 hours, 2 weeks and 6 weeks following the intervention.

COVID-associated changes in substance use will be quantified over three telephone interviews: one at the end of March / beginning of April 2020 (at the start of the pandemic), one at the end of April / beginning of May, and a final one which will be instituted if feasible once the infection rates and social distancing policies have decreased.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cigarette Smoking Addiction Nicotine Tobacco Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stress task and smoking cue

Exposure to a psychosocial stress task followed by smoking video cues

Group Type EXPERIMENTAL

Stress induction

Intervention Type BEHAVIORAL

Exposure to a psychosocial stressor

Cue induction

Intervention Type BEHAVIORAL

Exposure to a smoking-related task

Stress task and neutral cue

Exposure to a psychosocial stress task followed by neutral video cues

Group Type EXPERIMENTAL

Stress induction

Intervention Type BEHAVIORAL

Exposure to a psychosocial stressor

Neutral cue exposure

Intervention Type BEHAVIORAL

Exposure to neutral cues

Control task and smoking cue

Exposure to a control task followed by smoking video cues

Group Type ACTIVE_COMPARATOR

Control stress exposure

Intervention Type BEHAVIORAL

Exposure to a control task (no stress)

Cue induction

Intervention Type BEHAVIORAL

Exposure to a smoking-related task

Control task and neutral cue

Exposure to a control task followed by neutral video cues

Group Type ACTIVE_COMPARATOR

Control stress exposure

Intervention Type BEHAVIORAL

Exposure to a control task (no stress)

Neutral cue exposure

Intervention Type BEHAVIORAL

Exposure to neutral cues

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stress induction

Exposure to a psychosocial stressor

Intervention Type BEHAVIORAL

Control stress exposure

Exposure to a control task (no stress)

Intervention Type BEHAVIORAL

Cue induction

Exposure to a smoking-related task

Intervention Type BEHAVIORAL

Neutral cue exposure

Exposure to neutral cues

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Scoring 5 or higher on the Fagerström Test for Cigarette Dependence
* Willingness to abstain from smoking for 4 hours prior to each laboratory visit

Exclusion Criteria

* Currently using cigarette cessation products
* Endocrinological problems
* Significant mental or physical health conditions
* Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Marco Leyton

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marco Leyton

Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marco Leyton, PhD

Role: PRINCIPAL_INVESTIGATOR

McGill University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

McGill University

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Barnabe A, Gamache K, de Camargo JVP, Allen-Flanagan E, Rioux M, Pruessner J, Leyton M, Nader K. A novel stress-based intervention reduces cigarette use in non-treatment seeking smokers. Neuropsychopharmacology. 2023 Jan;48(2):308-316. doi: 10.1038/s41386-022-01455-6. Epub 2022 Sep 29.

Reference Type DERIVED
PMID: 36175551 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

421-0318

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smoking Cessation in Alcoholics
NCT00963482 COMPLETED NA